drugset / Trial / NCT05795140
Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS
NaSingle-groupOpen-labelTreatment
Summary
This is a multicenter, single arm, open-label, extension study to evaluate the long-term safety, tolerability, and efficacy of iptacopan in participants with aHUS.
Timeline
- Start
- 2024-05-08
- Primary completion
- 2032-07-16
- Completion
- 2032-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iptacopan | Small molecule | 200 mg | Oral |